#PureScience #Covid19
The AstraZeneca-Oxford vaccine has now had two participants report rare neurological reactions in a span of two months. ThePrint’s Sandhya Ramesh takes a look at these concerning findings and the implications for the viability fo the vaccine.
---------------------------------------------------------------------------------------------
AstraZeneca, Under Fire for Vaccine Safety, Releases Trial Blueprints [ Ссылка ]
---------------------------------------------------------------------------------------------
Participant information sheet: [ Ссылка ]
---------------------------------------------------------------------------------------------
AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K. [ Ссылка ]
------------------------------------------------------------------------------------------------------------------------------------------------------------------
Connect with ThePrint
» Subscribe to ThePrint : [ Ссылка ]
» Like us on Facebook: [ Ссылка ]
» Tweet us on Twitter: [ Ссылка ]
» Follow us on Instagram: [ Ссылка ]
» Find us on LinkedIn : [ Ссылка ]
» Subscribe to ThePrint on Telegram: [ Ссылка ]
